Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells

Stem Cells and Development

Volumn 16, Issue 5, 2007, Pages 719-731

  Chen, Lei ^a   Zhang, Wei ^a   Yue, Han ^a   Han, Qin ^b   Chen, Bin ^b   Shi, Mingxia ^b   Li, Jing ^b   Li, Binzong ^b   You, Shengguo ^a   Shi, Yufang ^c   Zhao, Robert Chunhua ^b,d  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2;

ARTICLE; CD34 SELECTION; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; ENDOCYTOSIS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 36248968773     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0065     Document Type: Article

References (42)

1. Reese JS, ON Koc and SL Gerson. (1999). Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction. J Hematother Stem Cell Res 8: 515-523.
2. Dormady SP, O Bashayan, R Dougherty, XM Zhang and RS Basch. (2001). Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res 10:125-140.
3. Wakitani S, T Saito and AI Caplan. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
4. Woodbury D, EJ Schwarz, DJ Prockop and IB Black. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364-370.
5. Kopen GC, DJ Prockop and DG Phinney. (1999). Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96: 10711-10716.
6. Toma C, MF Pittenger, KS Cahill, BJ Byrne and PD Kessler. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98.
7. Kawada H, J Fujita, K Kinjo, Y Matsuzaki, M Tsuma, H Miyatake, Y Muguruma, K Tsuboi, Y Itabashi, Y Ikeda, S Ogawa, H Okano, T Hotta, K Ando and K Fukuda. (2004). Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104:3581-3587.
8. Pittenger MF and BJ Martin. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20.
9. Pereira RF, MD O'Hara, AV Laptev, KW Halford, MD Pollard, R Class, D Simon, K Livezey and DJ Prockop. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142-1147.
10. Liechty KW, TC MacKenzie, AF Shaaban, A Radu, AM Moseley, R Deans, DR Marshak and AW Flake. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Med 6:1282-1286.
11. Deans RJ and AB Moseley. (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884.
12. Uccelli A, L Moretta and V Pistoia. (2006). Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566-2573.
13. Le Blanc K, C Tammik, K Rosendahl, E Zetterberg and O Ringden. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896.
14. Frassoni FLM, Bacigalupo A and G E. (2002). Expanded mesenchymal stem cells (MSC), coinfused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis. Bone Marrow Transplant 29:75.
15. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441.
16. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
17. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90:516-525.
18. Zhang W, W Ge, C Li, S You, L Liao, Q Han, W Deng and RC Zhao. (2004). Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13: 263-271.
19. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
20. Beyth S, Z Borovsky, D Mevorach, M Liebergall, Z Gazit, H Aslan, E Galun and J Rachmilewitz. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219.
21. Spaggiari GM, A Capobianco, S Becchetti, MC Mingari and L Moretta. (2006). Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484-1490.
22. Banchereau J and RM Steinman. (1998). Dendritic cells and the control of immunity. Nature 392:245-252.
23. Rissoan MC, V Soumelis, N Kadowaki, G Grouard, F Briere, R de Waal Malefyt and YJ Liu. (1999). Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-1186.
24. Gilliet M and YJ Liu. (2002). Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695-704.
25. Fitzgerald-Bocarsly, P. 1993. Human natural interferon-alpha producing cells. Pharmacol Therapeut 60:39-62.
26. Guo H, B Fang, L Liao, Z Zhao, J Liu, H Chen, SH Hsu, Q Cui and RC Zhao. (2003). Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-) CD34(-) cells. Exp Hematol 31:650-658.
27. Caux C, C Dezutter-Dambuyant, D Schmitt and J Banchereau. (1992). GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261.
28. Chen W, S Antonenko, JM Sederstrom, X Liang, AS Chan, H Kanzler, B Blom, BR Blazar and YJ Liu. (2004). Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 103:2547-2553.
29. Kalinski P, CM Hilkens, A Snijders, FG Snijdewint and ML Kapsenberg. (1997). IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159:28-35.
30. Deng W, Q Han, L Liao, C Li, W Ge, Z Zhao, S You, H Deng and RC Zhao. (2004). Allogeneic bone marrow-derived flk-1+Sca-1-mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol 32:861-867.
31. Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K McIntosh, S Patil, W Hardy, S Devine, D Ucker, R Deans, A Moseley and R Hoffman. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
32. Koc ON and HM Lazarus. (2001). Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 27:235-239.
33. Dzionek A, A Fuchs, P Schmidt, S Cremer, M Zysk, S Miltenyi, DW Buck and J Schmitz. (2000). BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165: 6037-6046.
34. Buelens C, V Verhasselt, D De Groote, K Thielemans, M Goldman and F Willems. (1997). Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 27:756-762.
35. Buelens C, F Willems, A Delvaux, G Pierard, JP Delville, T Velu and M Goldman. (1995). Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 25:2668-2672.
36. Robinson SP, S Patterson, N English, D Davies, SC Knight and CD Reid. (1999). Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 29:2769-2778.
37. Harris SG, J Padilla, L Koumas, D Ray and RP Phipps. (2002). Prostaglandins as modulators of immunity. Trends Immunol 23:144-150.
38. Harizi H, M Juzan, C Grosset, M Rashedi and N Gualde. (2001). Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells. Cell Immunol 209: 19-28.
39. Kalinski P, CM Hilkens, A Snijders, FG Snijdewint and ML Kapsenberg. (1997). Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv Exp Med Biol 417:363-367.
40. Arpinati M, CL Green, S Heimfeld, JE Heuser and C Anasetti. (2000). Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95: 2484-2490.
41. Waller EK, H Rosenthal, TW Jones, J Peel, S Lonial, A Langston, I Redei, I Jurickova and MW Boyer. (2001). Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 97:2948-2956.
42. Rossi M, M Arpinati, D Rondelli and C Anasetti. (2002). Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation? Hum Immunol 63:1194-1200.